This patent covers induction of neural regeneration through administration of monocytes and other immune cells. The immune cells may be administered for the treatment of spinal cord injury. This is actually in clinical trials right now.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.